Username:
Password:
Remember Me.


Our team of journalists reports each day (Mon-Fri) on the latest opinions, recommendations, targets and forecasts by the ten leading stock brokers and equity investment advisers in the Australian market.

The Australian Broker Call is made available to its subscribers each morning before the opening of the Australian share market at 10am.



Our tagline 'Offers Unprecedented Insights Into The Australian Share Market' already gives it away. This report combines all the information available in the FN Arena database and makes it accessible in an easy to use monthly pdf report.

Subscribers to the Australian Broker Call Report now have access to five additional services which, together, add tremendous value to our daily news report. (For an overview of all services, please see the signup page on this website).

We strongly believe the combination of all our products offers our subscribers with better insight into what's happening in the Australian share market by revealing the underlying views and sentiments that drive share price valuations either northward, or southward.



Weekly Top Ten News Stories
Our top ten news stories from 20 November 2014 to 27 November 2014
General Disappointment Weighs Down Investor Enthusiasm
The results of the November Australian Investors' Sentiment Survey are out, and they make for a sobering assessment.
Your Editor On Twitter
This week's Tweets on Twitter by Your Editor.
Next Week At A Glance
A brief look at important company events and economic data releases next week.
Weekly Broker Wrap: Term Deposits, Supermarkets, Sales And FX Strategy
Term deposits are less attractive; food inflation easing; Woolworths' Masters dilemma; business sales; and ANZ's FX strategy.
The Overnight Report: OPEC Takes A Stand
No cuts, said OPEC, as America passed the cranberry sauce. Brent crude down five dollars. (Accessible only for subscribers before 10:15 AEST)
Today's Financial Calendar
Significant Scheduled Events For 28 November, 2014
Mesoblast's GvHD Therapy Could Be Pivotal
Baillieu Holst is enthusiastic about Mesoblast's plans to launch stem cell therapy for GvHD in 2016 and believes upside potential for the stock is substantial.
The Short Report
FNArena's weekly update on short positions in the Australian share market.
Australian Corporate Bond Price Tables
FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.
Material Matters: Oil & Gas, Copper And Thermal Coal
Tough times continue for oil & gas producers while copper and thermal coal surpluses are likely for the next couple of years.
Technology One Cloud Impact Unclear
Technology One's potential in cloud software is unquestioned but brokers remain concerned about the near-term revenue impact from migrating customers.

There's more news inside. Simply sign up for a free trial (no obligation) and receive daily and weekly emails. You can always unsubscribe later.

The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
© News Network 2014. All Rights Reserved. No portion of this website may be reproduced, copied or in any way re-used without written permission from News Network. All subscribers should read our terms and conditions.